ECU

搜索文档
KBR Investor News: If You Have Suffered Losses in KBR, Inc. (NYSE: KBR), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
GlobeNewswire News Room· 2025-07-26 05:19
NEW YORK, July 25, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of KBR, Inc. (NYSE: KBR) resulting from allegations that KBR may have issued materially misleading business information to the investing public. SO WHAT: If you purchased KBR securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law F ...
Gray Announces Closing of Offering of $775 Million of 7.250% Senior Secured First Lien Notes due 2033
Globenewswire· 2025-07-26 04:30
ATLANTA, July 25, 2025 (GLOBE NEWSWIRE) -- Gray Media, Inc. (“Gray”) (NYSE: GTN) announced today that it has completed its previously announced offering of $775 million aggregate principal amount of 7.250% senior secured first lien notes due 2033 (the “Notes”). The Notes were issued at par. The net proceeds from the Notes are being used (i) to repay a portion of Gray’s term loan D due December 1, 2028 (the “Term Loan D”), (ii) to repay a portion of Gray’s term loan F due June 4, 2029 (the “Term Loan F”), (i ...
AMERICAN CENTURY INVESTMENTS ANNOUNCES CHANGE TO ETF LINEUP
Prnewswire· 2025-07-26 04:16
KANSAS CITY, Mo., July 25, 2025 /PRNewswire/ -- American Century Investments® today announces plans to close and liquidate American Century Quality Preferred ETF (QPFF) and American Century Quality Convertible Securities ETF (QCON).QPFF and QCON will cease trading on the Cboe BZX Exchange Inc. at the close of the market on September 8, 2025. After this date, shareholders will be unable to dispose of their shares on the Cboe BZX Exchange, Inc. On or about September 15, 2025, the funds will liquidate and dist ...
VCI Global Launches SecureGPU™ – First Encrypted AI Compute Server for Sovereign and Defense Applications
Globenewswire· 2025-07-26 03:30
SecureGPU™ Marks Milestone in Zero-Trust AI Infrastructure; Now Piloting Across Southeast AsiaKUALA LUMPUR, Malaysia, July 25, 2025 (GLOBE NEWSWIRE) -- VCI Global Limited (NASDAQ: VCIG) (“VCI Global” or the “Company”), a diversified global holding company with a strategic focus on AI & Robotics, Fintech, Cybersecurity, Capital Market Consultancy, today announced the launch of SecureGPU™, a next-generation encrypted AI compute server developed by its cybersecurity and infrastructure subsidiary, V Gallant Sdn ...
How Palantir, Tempus, Nvidia-Backed Recursion Are Disrupting Big Pharma
Benzinga· 2025-07-26 01:53
Imagine you stepped into the dimly lit hospital meeting room to pitch a new cancer‑diagnostic deal. You flick through slides powered by Palantir Technologies Inc.'s PLTR Foundry platform, showcasing data transparency and precision that would make legacy pharma pipelines look prehistoric.Track Palantir’s stock moves here.Down the hall, Tempus AI Inc TEM had its own room, where genomics-powered diagnostics promised to cut months off drug development timelines. Across the corridor, Recursion Pharmaceuticals In ...
Southside Bancshares(SBSI) - 2025 Q2 - Earnings Call Transcript
2025-07-26 01:00
Southside Bancshares (SBSI) Q2 2025 Earnings Call July 25, 2025 12:00 PM ET Speaker0Thank you for standing by, and welcome to Southside Bancshares' Second Quarter twenty twenty five Earnings Conference Call. At this time, all participants are in a listen only mode. After the speaker presentation, there will be a question and answer session. To ask a question during the session, you will need to press 11 on your telephone. To remove yourself from the queue, you may press 11 again.I would now like to hand the ...
RXRX vs. RLAY: Which Precision Biotech Stock is a Better Bet Now?
ZACKS· 2025-07-26 00:36
Key Takeaways RXRX has shifted focus to REC-4881 and cancer candidates after discontinuing three key programs.RXRX reported $15M in Q1 revenues and holds $509M in cash, funding ops into mid-2027.RLAY narrowed its pipeline, cut costs and lost a Roche partnership, limiting near-term revenue streams.Recursion Pharmaceuticals (RXRX) and Relay Therapeutics (RLAY) are pioneering the use of artificial intelligence (AI) in drug discovery for various indications across different disease areas. They leverage machine ...
BAESY or NOC: Which Stock Stands Stronger in Today's Defense Boom?
ZACKS· 2025-07-25 23:31
Key Takeaways BAESY's 2025 EPS is expected to grow 37.7%, while NOC's is projected to decline 3.7%.BAESY shares surged 53.9% over the past year, outpacing NOC's 18.3% gain.NOC trades at a lower forward P/E than BAESY, but shows slower growth and falling EPS estimates.As rising geopolitical tensions across the globe drive up military budgets, defense companies like BAE Systems plc ((BAESY) and Northrop Grumman ((NOC) are seeing strong investor interest. Increased spending on advanced defense technologies, eq ...
Orchid Island Capital(ORC) - 2025 Q2 - Earnings Call Transcript
2025-07-25 23:00
Orchid Island Capital (ORC) Q2 2025 Earnings Call July 25, 2025 10:00 AM ET Speaker0Good morning, and welcome to the Second Quarter twenty twenty five Earnings Conference Call for Orchid Island Capital. This call is being recorded today, 07/25/2025. At this time, the company would like to remind listeners that statements made during today's conference call related at this time, the company would like to remind listeners that statements made during today's conference call relating to matters that are not his ...
Seeking Clues to Hologic (HOLX) Q3 Earnings? A Peek Into Wall Street Projections for Key Metrics
ZACKS· 2025-07-25 22:16
In its upcoming report, Hologic (HOLX) is predicted by Wall Street analysts to post quarterly earnings of $1.05 per share, reflecting a decline of 0.9% compared to the same period last year. Revenues are forecasted to be $1.01 billion, representing a year-over-year decrease of 0.4%.The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.Prior to a company's ea ...